The analysis included 241 adults treated between 2009 and 2023. The researchers found that high-dose doxycycline was associated with significantly higher rates of adverse effects (AEs), most commonly ...

Piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment.

Get Instant Summarized Text (Gist) Antibiotic resistance among key bacterial species tends to stabilize over time rather than increase indefinitely. Analysis of over 3 million samples from 30 ...

Doxycycline has a higher incidence of photosensitivity than other antibiotics used for acne. The hematologic status of patients on sulfamethoxazole-trimethoprim must be closely monitored.

Researchers tracking the bacteria causing typhoid fever, Salmonella Typhi, have observed increasing antibiotic resistance due to genetic adaptations. In discussion with The Guardian, Jehan Zeb ...

Low-dose doxycycline showed comparable efficacy with high-dose treatment in patients with lymphocytic scarring alopecia, with a lower rate of adverse events (AEs) and related discontinuations.

A new modeling study highlights the potential threat that human antibiotic use may pose to global waterways, researchers reported yesterday in the journal PNAS Nexus. The presence of antibiotic ...

Antibiotic resistance tends to stabilize over time, according to a new study. Antibiotic resistance tends to stabilize over time, according to a study published April 3, 2025 in the open-access ...

They found a new molecule named lariocidin—a potential new antibiotic with the power to kill some of the world’s most drug-resistant bacteria. The molecule belongs to a rare class called lasso ...

A 2023 study found that prior antibiotic use was associated with an increased risk of IBS. IBS causes long-term abdominal pain and bowel changes such as constipation, diarrhea, and bloating.

Scientists at Roche and Harvard University have discovered an entirely new class of antibiotic that can kill a highly drug-resistant ‘superbug’ with a mortality rate that can be upwards of 50% ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...